AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Unio...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 0.0% | ||
| P/E Ratio | -4.1x | ||
| Revenue | 64.251 M | ||
| Net Income to Company | -61.845 M |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 34 | 50 | 64 | 14 | 18 |
| Operating Income | (28) | (43) | (57) | (12) | (9.96) |
| Net Profit | (27) | (35) | (62) | (7.07) | (12) |
| Diluted EPS | -1.07 | -1.40 | -2.39 | -0.28 | -0.44 |
| EBITDA | (27) | (42) | (55) | (12) | (9.55) |
| Balance Sheet | |||||
| Cash & ST Invest. | 79 | 89 | 36 | 89 | 36 |
| Current Assets | 87 | 104 | 57 | 104 | 57 |
| Total Assets | 98 | 112 | 80 | 112 | 80 |
| Current Liabilities | 11 | 13 | 20 | 13 | 20 |
| Total Liabilities | 14 | 63 | 75 | 63 | 75 |
| Total Equity | 85 | 49 | 4.50 | 49 | 4.50 |
| Total Debt | 0.92 | 42 | 46 | 42 | 46 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (19) | (38) | (49) | (11) | (8.08) |
| Cash From Investing | (19) | 1.61 | 37 | (57) | 2.47 |
| Cash From Financing | 0.90 | 40 | 3.51 | 39 | 1.02 |
| Free Cash Flow | (20) | (39) | (58) | (11) | (9.69) |